Clínica Universidad de Navarra/CIMA

FACTS AND HOPES IN

CANCER IMMUNOTHERAPY

Madrid. Nov. 22nd and 23rd, 2019

EVENT WILL START IN
  • 00

    days

  • 00

    hours

  • 00

    minutes

  • 00

    seconds

Add to My Calendar 2019-11-22 14:30:00 2019-11-23 19:30:00 Europe/Madrid CANCER IMMUNOTHERAPY DAY Gather is a responsive event theme with many awesome features including add to my calendar feature. Awesome. huh? Madrid, España Clínica Universidad de Navarra / CIMA cancimmunoday@unav.es

FULL PROGRAM

DOWNLOAD PROGRAM

Opening

  • Esperanza Lozano. Director CUN Madrid
14.20-14.30

KEYNOTE LECTURE

 

Chairs:

  • Ignacio Melero, CUN-CIMA.
  • Francisco Sánchez-Madrid, CNIC- Hospital de La Princesa

 

  • “NK cell-based Tumor Therapies”.
    Lorenzo Moretta. Ospedale Pediatrico Bambino Gesù. Rome
14.30-15.15

Session 1. CROSSPRIMING AND CANCER

Chairs:

  • David Sancho, CNIO. Alvaro Teijeira, CIMA

 

  • “Crosspriming”.
    Sebastian Amigorena Institut Curie. Paris
  • “Inflammation and cancer immunogenicity”.
    Santiago Zelenay. The University of Manchester. UK
  • “cDC1 and hot tumors”.
    Jason Luke. University of Chicago Medicine. Chicago
15.15-17.15

Coffee Break

17.15-18.00

Session 2. RADIOIMMUNOTHERAPY

Sponsored by EMD

Chairs:

  • Felipe Calvo, CUN

 

  • “Obligometastasis and radiotherapy”.
    Ralph R. Weichselbaum. University of Chicago Medicine. Chicago
  • “Radiotherapy and virotherapy”.
    Kevin Harrington. The Institute of Cancer Research, London
  • “Abscopal effects of radioimmunotherapy”.
    María Rodríguez Ruiz. CUN. Pamplona
18.00-20.00

Session 3. FACTS AND HOPES REACHING THE CLINIC (I)

Chairs:

  • Cristina Mingari, University of Genova. Ospedale Policlinico San Martino – IRCCS
  • Mariano Ponz, CUN

 

  • “Immunotherapy of primary liver cancer”.
    Bruno Sangro. CUN. Pamplona
  • “Immunotherapy of colon cancer”.
    Guillem Argilés. Vall d’Hebron Institute of Oncology (VHIO), Barcelona
  • “New targets in immunotherapy: LAG3-FGL1 and SIGLEC 152”.
    Jun Wang. NY University
8.30-10.30

Coffee Break

10.30-11.00

KEYNOTE LECTURE

Chairs:

  • Pedro Berraondo, CIMA.
  • Noelia Casares, CIMA

 

  • “Creative biotechnology for cancer immunotherapy”
11.00-11.45

Session 4. ADOPTIVE T-CELL THERAPY

Sponsored by GILEAD

Chairs:

  • Juan J. Lasarte, CIMA.
  • Paloma Sánchez-Mateos, Universidad Complutense de Madrid

 

  • “An introduction to adoptive T-Cell therapy”.
    Sandra Hervás. CIMA. Pamplona
  • “TIL Therapy”.
    Inge Marie Svane. University of Copenhagen. Dinamarca
  • “CAR T-Cell Therapy”.
    Marcela Maus. MGH Center for Cancer Research. Charlestown
11.45-13.45

Lunch Break

13.45-15.30

Session 5. FACTS AND HOPES REACHING THE CLINIC (II)

Chairs:

  • Eduardo Castañón, CUN.
  • Miguel Fernández de Sanmamed, CUN

 

  • “Immunotherapy of urogenital cancer”.
    José Luis Pérez Gracia. CUN. Pamplona
  • “Immunotherapy of ovarian cancer”.
    Antonio González. Madrid
  • “Immunotherapy of melanoma”.
    José María Piulats. IDI Bellvitge, Barcelona
15.30-17.30

ROUND TABLE “EARLY PHASE CLINICAL TRIALS IN CANCER IMMUNOTHERAPY”

Chairs:

  • Ignacio Melero, CUN. Eduardo Castañón, CUN

Panelists:

  • Emiliano Calvo. Centro Integral Oncológico Clara Campal. Madrid
  • Elena Garralda. Vall d’Hebron Institute of Oncology (VHIO). Barcelona
  • María Rodríguez Ruiz. CUN. Pamplona
  • Iván Márquez Rodas. Hospital General Universitario Gregorio Marañón. Madrid
  • Mariano Ponz. CUN. Pamplona
17.30-18.15

EVENT SUPPORTED BY

PLATINUM

Bristol-Myers-Squibb
Kite-Gilead-Company

GOLD

merck-cancerimmunotherapyday-cun

SILVER

Astrazeneca-CancerInmunotherapyDay
Alligator-Bioscience

BRONZE

Ciberonc

email-icon

CONTACT

Clínica Universidad de Navarra / CIMA

Cibeles Pinto

cancimmunoday@unav.es

+34 948194700 x 4012

location-icon

ADDRESS

Fundación Ramón Areces

Calle Vitruvio, 5,
28006 Madrid, Spain

Time: 9:30 AM to 19:00 PM. Monday to friday

SEND US A MESSAGE

If you have any questions about the event, please contact us directly. We will respond for sure.






back to top